384 related articles for article (PubMed ID: 30396425)
1. Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases.
Lafaye P; Li T
Comp Immunol Microbiol Infect Dis; 2018 Oct; 60():17-22. PubMed ID: 30396425
[TBL] [Abstract][Full Text] [Related]
2. Nanobodies: natural single-domain antibodies.
Muyldermans S
Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
[TBL] [Abstract][Full Text] [Related]
3. Applications of Nanobodies.
Muyldermans S
Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
[TBL] [Abstract][Full Text] [Related]
4. A guide to: generation and design of nanobodies.
Muyldermans S
FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
[TBL] [Abstract][Full Text] [Related]
5. Exploiting Nanobodies' Singular Traits.
Ingram JR; Schmidt FI; Ploegh HL
Annu Rev Immunol; 2018 Apr; 36():695-715. PubMed ID: 29490163
[TBL] [Abstract][Full Text] [Related]
6. The development of nanobodies for therapeutic applications.
Van Bockstaele F; Holz JB; Revets H
Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
[TBL] [Abstract][Full Text] [Related]
7. Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies.
Perruchini C; Pecorari F; Bourgeois JP; Duyckaerts C; Rougeon F; Lafaye P
Acta Neuropathol; 2009 Nov; 118(5):685-95. PubMed ID: 19597828
[TBL] [Abstract][Full Text] [Related]
8. Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma.
Bannas P; Koch-Nolte F
Front Immunol; 2018; 9():2559. PubMed ID: 30459772
[TBL] [Abstract][Full Text] [Related]
9. Introduction to heavy chain antibodies and derived Nanobodies.
Vincke C; Muyldermans S
Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
[TBL] [Abstract][Full Text] [Related]
10. Application of camelid heavy-chain variable domains (VHHs) in prevention and treatment of bacterial and viral infections.
Wilken L; McPherson A
Int Rev Immunol; 2018 Jan; 37(1):69-76. PubMed ID: 29182399
[TBL] [Abstract][Full Text] [Related]
11. Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries.
Rossotti MA; Trempe F; van Faassen H; Hussack G; Arbabi-Ghahroudi M
Methods Mol Biol; 2023; 2702():107-147. PubMed ID: 37679618
[TBL] [Abstract][Full Text] [Related]
12. Single domain antibodies from camelids in the treatment of microbial infections.
De Greve H; Fioravanti A
Front Immunol; 2024; 15():1334829. PubMed ID: 38827746
[TBL] [Abstract][Full Text] [Related]
13. Enteric pharmacokinetics of monomeric and multimeric camelid nanobody single-domain antibodies.
Debatis M; Danz H; Tremblay JM; Gaspie K; Kudej RK; Vigdorovich V; Sather N; Jaskiewicz JJ; Tzipori S; Shoemaker CB
PLoS One; 2023; 18(11):e0291937. PubMed ID: 38011121
[TBL] [Abstract][Full Text] [Related]
14. Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?
Smolarek D; Bertrand O; Czerwinski M
Postepy Hig Med Dosw (Online); 2012 Jun; 66():348-58. PubMed ID: 22706121
[TBL] [Abstract][Full Text] [Related]
15. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains.
Hussack G; Ryan S; van Faassen H; Rossotti M; MacKenzie CR; Tanha J
PLoS One; 2018; 13(12):e0208978. PubMed ID: 30540857
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.
Hussack G; Arbabi-Ghahroudi M; Mackenzie CR; Tanha J
Methods Mol Biol; 2012; 911():211-39. PubMed ID: 22886255
[TBL] [Abstract][Full Text] [Related]
18. Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications.
Yu X; Xu Q; Wu Y; Jiang H; Wei W; Zulipikaer A; Guo Y; Jirimutu ; Chen J
Biomater Sci; 2020 Jul; 8(13):3559-3573. PubMed ID: 32490444
[TBL] [Abstract][Full Text] [Related]
19. In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody.
Richard G; Meyers AJ; McLean MD; Arbabi-Ghahroudi M; MacKenzie R; Hall JC
PLoS One; 2013; 8(7):e69495. PubMed ID: 23894495
[TBL] [Abstract][Full Text] [Related]
20. Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay.
Kim HJ; McCoy MR; Majkova Z; Dechant JE; Gee SJ; Tabares-da Rosa S; González-Sapienza GG; Hammock BD
Anal Chem; 2012 Jan; 84(2):1165-71. PubMed ID: 22148739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
